Intestinal absorption and permeability in human immunodeficiency virus- infected patients

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 1, 1999, Pages 29-34

  Pernet, Pascal ^a,b,c   Vittecoq, D ^a,b,c   Kodjo, A ^a,b,c   Randrianarisolo, M H ^a,b,c   Dumitrescu, L ^a,b,c   Blondon, H ^a,b,c   Bergmann, J F ^a,b,c   Giboudeau, J ^a,b,c   Aussel, C ^a,b,c  

^a HÔPITAL SAINT ANTOINE   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c Hôpitaux Universitaires Henri Mondor   (France)

Author keywords

Acquired immunodeficiency syndrome; Diarrhoea; Intestinal permeability; Malabsorption; Nutritional status

Indexed keywords

ALBUMIN; CD4 ANTIGEN; CREATININE; DIDANOSINE; LACTULOSE; LAMIVUDINE; MANNITOL; STAVUDINE; XYLOSE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; COLORIMETRY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL;

ADULT; AGED; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; CREATININE; DIARRHEA; FEMALE; HIV INFECTIONS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; LACTULOSE; MALE; MANNITOL; MIDDLE AGED; NUTRITIONAL STATUS; SERUM ALBUMIN; WEIGHT LOSS; XYLOSE;

EID: 0032973729     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529950172790     Document Type: Article

References (32)

1. 1. Mayer HB, Wanke CA. Diagnostic strategies in HIV-infected patients with diarrhoea. AIDS 1994;8:1639-48.
2. 2. Ullrich R, Heise W, Bergs C, L'Age M, Riecken EO, Zeitz M. Gastrointestinal symptoms in patients infected with human immunodeficiency virus: relevance of infective agents isolated with gastrointestinal tract. Gut 1992;33:1080-4.
3. 3. Nelson JA, Wiley CA, Reynolds-Kohler C, Reese CE, Margeretten W, Levy JA. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1988;1:259-62.
4. 4. Ullrich R, Heise W, Bergs C, L'Age M, Riecken EO, Zeitz M. Effects of zidovudine treatment on the small intestinal mucosa in patients infected with the human immunodeficiency virus. Gastroenterology 1992;102:1483-92.
5. 5. Ullrich R, Zeitz M, Heise W, L'Age M, Höffker G, Riecken EO. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med 1989;111:15-21.
6. 6. Heise C, Dandekar S, Kuman P, Duplanter R, Donovan R, Halsted CH. Human immunodeficiency virus infection of enterocytes and mononuclear cells in human jejunal mucosa. Gastroenterology 1991;100:1521-7.
7. 7. Kotler DP, Gaetz HP, Lange M, Klein EB, Holt PR. Enteropathy associated with acquired immunodeficiency syndrome. Ann Intern Med 1984;101:421-8.
8. 8. Cummins AG, Labrooy JT, Stanley DP, Rowland R, Shearman DJC. Quantitative histological study of enteropathy associated with HIV infection. Gut 1990;31:317-21.
9. 9. Verdon R, René E. Pathologie digestive au cours de l'infection par le VIH: conséquences fonctionnelles et nutritionnelles. Nutr Clin Metabol 1993;7:161-8.
10. 10. Lim SG, Menzies IS, Lee CA, Johnson A, Pounder RE. Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease. Scand J Gastroenterol 1993;28:573-80.
11. 11. Keating J, Bjarnason I, Somasundaram S, Macpherson A, Francis N, Price AB, et al. Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut 1995;37:623-9.
12. 12. Goodgame RW, Kimball K, Ou CN, White AC Jr, Genta RM, Lifschitz CH, et al. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 1995;108:1075-82.
13. 13. Lima AA, Silva TM, Gifoni AM, Barrett LJ, McAuliffe IT, Bao Y, et al. Mucosal injury and disruption of intestinal barrier function in HIV-infected individuals with and without diarrhea and cryptosporidiosis in northeast Brazil. Am J Gastroenterol 1997;92:1861-6.
14. 14. Bjarnason I, Sharpstone DR, Francis N, Marker A, Taylor C, Barrett M, et al. Intestinal inflammation, ileal structure and function in HIV. AIDS 1996;10:1385-91.
15. 15. Craig RM, Atkinson AJ Jr. D-xylose testing: a review. Gastroenterology 1988;95:223-31.
16. 16. Hollander D. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 1992;27:721-6.
17. 17. Anonymous. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS amongst adolescents and adults. Morbid Mortal Weekly 1992;41:1-18.
18. 18. Dumas F, Aussel C, Pernet P, Martin C, Giboudeau J. Gas chromatography applied to the lactulose-mannitol intestinal permeability test. J Chromatogr B 1994;645:276-81.
19. 19. Roe JH, Rice EW. A photometric method for determination of free pentoses in animal tissues. J Biol Chem 1948;173:507-12.
20. 20. Klein S. The myth of serum albumin as a measure of nutritional status. Gastroenterology 1990;99:1845-6.
21. 21. Laine L, Garcia F, MC Gilligan K, Malinko A, Sinatra FR, Thomas DW. Protein-losing enteropathy and hypoalbuminemia in AIDS. AIDS 1993;7:837-40.
22. 22. Gillin JS, Shike MS, Alcock N, Urmacher C, Krown S, Kurtz RC, et al. Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome. Ann Intern Med 1985;102:619-22.
23. 23. Sahai J, Gallicano K, Swick L, Taylor S, Garber G, Seguin I, et al. Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection. Ann Intern Med 1997;127:289-93.
24. 24. Greenson JK, Belitsos PC, Yardley JH, Bartlett JG. AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhoea. Ann Intern Med 1991;114:366-72.
25. 25. Madi K, Trajman A, da Silva CF, Barroso PF, Belo MT, Cunha JM, et al. Jejunal biopsy in HIV-infected patients. J Acquir Immune Defic Syndr 1991;4:930-7.
26. 26. Kotler DP, Reka S, Chow K, Orenstein JM. Effects of enteric parasitoses and HIV infection upon small intestinal structure and function in patients with AIDS. J Clin Gastroenterol 1993;16: 10-5.
27. 27. Asmuth DM, Hammer SM, Wanke CA. Physiological effects of HIV infection on human intestinal epithelial cells: an in vitro model for HIV enteropathy. AIDS 1994;8:205-11.
28. 28. Kapembwa MS, Fleming SC, Sewankambo N, Serwadda D, Lucas S, Moody A, et al. Altered small-intestine permeability associated with diarrhoea in human-immunodeficiency-virus-infected Caucasian and African subjects. Clin Sci 1991;81:327-34.
29. 29. Tepper RE, Simon D, Brandt LJ, Nutovits R, Lee MJ. Intestinal permeability in patients infected with the human immunodeficiency virus. Am J Gastroenterol 1994;89:878-82.
30. 30. Stockmann M, Fromm M, Schmitz H, Schmidt W, Riecken EO, Schultzke J. Duodenal biopsies of HIV-infected patients with diarrhoea exhibit epithelial barrier defects but no active secretion. AIDS 1998;12:43-51.
31. 31. Elia M, Behrens R, Northrop C, Wraight P, Neale G. Evaluation of mannitol, lactulose and 51 Cr-labelled ethylenediaminetetra-acetate as markers of intestinal permeability in man. Clin Sci 1987;73:197-204.
32. 32. Rolston DDK, Mathan VI. Xylose transport in the human jejunum. Dig Dis Sci 1989;34:553-8.